Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
306.4 INR | +5.06% | +17.10% | +22.73% |
18/04 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
18/04 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Bullish |
Resistance | 326.95 | 339.00 | 326.95 |
Spread/Res. | -6.29% | -9.62% | -6.29% |
Spread/Supp. | +10.10% | +17.10% | +17.10% |
Support | 278.30 | 261.65 | 261.65 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- BIOCON Stock
- Charts Biocon Limited